Low-Dose Naltrexone (LDN) – American ME and CFS Society [online]. [cit. 2024-06-04]. Dostupné online. (anglicky)
Zyrtec (cetirizine) – American ME and CFS Society [online]. [cit. 2024-06-04]. Dostupné online. (anglicky)
Rituxan (rituximab) – American ME and CFS Society [online]. [cit. 2024-06-04]. Dostupné online. (anglicky)
berlincures.com
BC 007 Pipeline. www.berlincures.com [online]. [cit. 2024-06-04]. Dostupné online.
biomedcentral.com
trialsjournal.biomedcentral.com
BRUUN, Karin Due; AMRIS, Kirstine; VAEGTER, Henrik Bjarke. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021-12, roč. 22, čís. 1. Dostupné online [cit. 2024-06-04]. ISSN1745-6215. DOI10.1186/s13063-021-05776-7. (anglicky)
VALDEZ, Ashley R.; HANCOCK, Elizabeth E.; ADEBAYO, Seyi. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Frontiers in Pediatrics. 2019-01-08, roč. 6. Dostupné online [cit. 2024-06-03]. ISSN2296-2360. DOI10.3389/fped.2018.00412.
WALLIN, Mitchell T.; CULPEPPER, William J.; CAMPBELL, Jonathan D. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019-03-05, roč. 92, čís. 10. Dostupné online [cit. 2024-06-03]. ISSN0028-3878. DOI10.1212/WNL.0000000000007035. PMID30770430. (anglicky)
TIAN, Jingru; ZHANG, Dingyao; YAO, Xu. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Annals of the Rheumatic Diseases. 2023-03-01, roč. 82, čís. 3, s. 351–356. PMID: 36241363. Dostupné online [cit. 2024-06-03]. ISSN0003-4967. DOI10.1136/ard-2022-223035. PMID36241363. (anglicky)
LAM, Marco Ho-Bun; WING, Yun-Kwok; YU, Mandy Wai-Man. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine. 2009-12-14, roč. 169, čís. 22, s. 2142–2147. PMID: 20008700. Dostupné online [cit. 2024-06-02]. ISSN1538-3679. DOI10.1001/archinternmed.2009.384. PMID20008700.
BATEMAN, Lucinda; BESTED, Alison C.; BONILLA, Hector F. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clinic Proceedings. 2021-11, roč. 96, čís. 11, s. 2861–2878. Dostupné online [cit. 2024-06-04]. DOI10.1016/j.mayocp.2021.07.004. (anglicky)
BAKER, Meghan; YOKOE, Deborah S.; STELLING, John. Automated Outbreak Detection of Hospital-Associated Infections. Open Forum Infectious Diseases. 2015, roč. 2, čís. suppl_1. Dostupné online [cit. 2024-06-04]. ISSN2328-8957. DOI10.1093/ofid/ofv131.60.
HAKIM, Alan; DE WANDELE, Inge; O'CALLAGHAN, Chris. Chronic fatigue in Ehlers–Danlos syndrome—Hypermobile type. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017-03, roč. 175, čís. 1, s. 175–180. Dostupné online [cit. 2024-06-04]. ISSN1552-4868. DOI10.1002/ajmg.c.31542. (anglicky)
WEIGEL, Breanna; EATON-FITCH, Natalie; THAPALIYA, Kiran. Symptom presentation and quality of life are comparable in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and post COVID-19 condition. Population Medicine. 2023-04-27, roč. 5, čís. Supplement. Dostupné online [cit. 2024-06-04]. ISSN2654-1459. DOI10.18332/popmed/165669.
Das Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen – IQWiG. Das Gesundheitswesen. 2018-12, roč. 80, čís. 12, s. 1107–1120. Dostupné online [cit. 2024-06-04]. ISSN0941-3790. DOI10.1055/a-0781-2253.
WEIGEL, Breanna; EATON-FITCH, Natalie; THAPALIYA, Kiran. Symptom presentation and quality of life are comparable in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and post COVID-19 condition. Population Medicine. 2023-04-27, roč. 5, čís. Supplement. Dostupné online [cit. 2024-06-04]. ISSN2654-1459. DOI10.18332/popmed/165669.
VINK, Mark; VINK-NIESE, Alexandra. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review. Health Psychology Open. 2018-07, roč. 5, čís. 2, s. 205510291880518. Dostupné online [cit. 2024-06-04]. ISSN2055-1029. DOI10.1177/2055102918805187. (anglicky)
HÄUSER, Winfried; BERNARDY, Kathrin; ÜÇEYLER, Nurcan. Treatment of Fibromyalgia Syndrome With Antidepressants: A Meta-analysis. JAMA. 2009-01-14, roč. 301, čís. 2, s. 198. Dostupné online [cit. 2024-06-04]. ISSN0098-7484. DOI10.1001/jama.2008.944. (anglicky)
BRUUN, Karin Due; AMRIS, Kirstine; VAEGTER, Henrik Bjarke. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021-12, roč. 22, čís. 1. Dostupné online [cit. 2024-06-04]. ISSN1745-6215. DOI10.1186/s13063-021-05776-7. (anglicky)
BONILLA, Hector; TIAN, Lu; MARCONI, Vincent C. Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. International Immunopharmacology. 2023-11, roč. 124, s. 110966. Dostupné online [cit. 2024-06-04]. DOI10.1016/j.intimp.2023.110966. (anglicky)
DIAZ-MITOMA, Francisco; TURGONYI, Eva; KUMAR, Ashok. Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®. Journal of Chronic Fatigue Syndrome. 2003-01, roč. 11, čís. 2, s. 71–95. Dostupné online [cit. 2024-06-04]. ISSN1057-3321. DOI10.1300/J092v11n02_06. (anglicky)
DE VINCI, Caterina; LEVINE, Paul H.; PIZZA, Giancarlo. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy. 1996-03-01, roč. 9, čís. 1, s. 87–90. Dostupné online [cit. 2024-06-04]. ISSN1573-8280. DOI10.1007/BF02628663. (anglicky)
MALTSEV, Dmitry. A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis. Microbiology and Immunology. 2022-04, roč. 66, čís. 4, s. 193–199. Dostupné online [cit. 2024-06-04]. ISSN0385-5600. DOI10.1111/1348-0421.12966. (anglicky)
LIANG, Shu-Ling; QUIRK, David; ZHOU, Aimin. RNase L: Its biological roles and regulation. IUBMB Life (International Union of Biochemistry and Molecular Biology: Life). 2006-09-01, roč. 58, čís. 9, s. 508–514. Dostupné online [cit. 2024-06-04]. ISSN1521-6543. DOI10.1080/15216540600838232.
FLUGE, Øystein; RISA, Kristin; LUNDE, Sigrid. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLOS ONE. 1. 7. 2015, roč. 10, čís. 7, s. e0129898. Dostupné online [cit. 2024-06-04]. ISSN1932-6203. DOI10.1371/journal.pone.0129898. PMID26132314. (anglicky)
BECKER, Niels-Peter; HABERLAND, Annekathrin; WENZEL, Katrin. A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. Clinical Drug Investigation. 2020-05, roč. 40, čís. 5, s. 433–447. Dostupné online [cit. 2024-06-04]. ISSN1173-2563. DOI10.1007/s40261-020-00903-9. (anglicky)
WILSHIRE, Carolyn; KINDLON, Tom; MATTHEES, Alem. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial. Fatigue: Biomedicine, Health & Behavior [online]. 2016-12-14fe [cit. 2017-05-18]. Dostupné online.
FALK HVIDBERG, Michael; BRINTH, Louise Schouborg; OLESEN, Anne V. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PloS One. 2015, roč. 10, čís. 7, s. e0132421. PMID: 26147503
PMCID: PMC4492975. Dostupné online [cit. 2024-06-02]. ISSN1932-6203. DOI10.1371/journal.pone.0132421. PMID26147503.
GHALI, Alaa; LACOUT, Carole; FORTRAT, Jacques-Olivier. Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2022-10, roč. 12, čís. 10, s. 2540. Dostupné online [cit. 2024-06-02]. ISSN2075-4418. DOI10.3390/diagnostics12102540. (anglicky)
doi.org
DEVANUR, L. D.; KERR, J. R. Chronic fatigue syndrome. Journal of Clinical Virology. 2006, roč. 37, čís. 3, s. 139–150. Dostupné online. ISSN1386-6532. (anglicky)
DE VINCI, Caterina; LEVINE, Paul H.; PIZZA, Giancarlo. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy. 1996-03-01, roč. 9, čís. 1, s. 87–90. Dostupné online [cit. 2024-06-04]. ISSN1573-8280. DOI10.1007/BF02628663. (anglicky)
elsevier.com
linkinghub.elsevier.com
BATEMAN, Lucinda; BESTED, Alison C.; BONILLA, Hector F. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clinic Proceedings. 2021-11, roč. 96, čís. 11, s. 2861–2878. Dostupné online [cit. 2024-06-04]. DOI10.1016/j.mayocp.2021.07.004. (anglicky)
BONILLA, Hector; TIAN, Lu; MARCONI, Vincent C. Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. International Immunopharmacology. 2023-11, roč. 124, s. 110966. Dostupné online [cit. 2024-06-04]. DOI10.1016/j.intimp.2023.110966. (anglicky)
europeanmecoalition.com
TEAM, EMEC. The European call on ME/CFS: an overview and what follows next • European ME Coalition [online]. 2022-12-12 [cit. 2024-06-04]. Dostupné online. (anglicky)
frontiersin.org
VALDEZ, Ashley R.; HANCOCK, Elizabeth E.; ADEBAYO, Seyi. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Frontiers in Pediatrics. 2019-01-08, roč. 6. Dostupné online [cit. 2024-06-03]. ISSN2296-2360. DOI10.3389/fped.2018.00412.
healthline.com
Multiple Sclerosis in Men: How It Differs from Women. Healthline [online]. 2021-10-27 [cit. 2024-06-03]. Dostupné online. (anglicky)
healthrising.org
JOHNSON, Cort. Abilify Shows Promise in Retrospective Chronic Fatigue Syndrome (ME/CFS) Study [online]. 2021-03-09 [cit. 2024-06-04]. Dostupné online. (anglicky)
jamanetwork.com
jama.jamanetwork.com
HÄUSER, Winfried; BERNARDY, Kathrin; ÜÇEYLER, Nurcan. Treatment of Fibromyalgia Syndrome With Antidepressants: A Meta-analysis. JAMA. 2009-01-14, roč. 301, čís. 2, s. 198. Dostupné online [cit. 2024-06-04]. ISSN0098-7484. DOI10.1001/jama.2008.944. (anglicky)
mayoclinic.org
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - Diagnosis and treatment - Mayo Clinic. www.mayoclinic.org [online]. [cit. 2024-06-04]. Dostupné online. (anglicky)
mdpi.com
GHALI, Alaa; LACOUT, Carole; FORTRAT, Jacques-Olivier. Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2022-10, roč. 12, čís. 10, s. 2540. Dostupné online [cit. 2024-06-02]. ISSN2075-4418. DOI10.3390/diagnostics12102540. (anglicky)
me-pedia.org
Post-exertional malaise. MEpedia: Encyclopedia of ME [online]. Last edited on August 27, 2023 [cit. 21.9.2023]. Dostupné online. (anglicky)
WALLIN, Mitchell T.; CULPEPPER, William J.; CAMPBELL, Jonathan D. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019-03-05, roč. 92, čís. 10. Dostupné online [cit. 2024-06-03]. ISSN0028-3878. DOI10.1212/WNL.0000000000007035. PMID30770430. (anglicky)
WALLIN, Mitchell T.; CULPEPPER, William J.; CAMPBELL, Jonathan D. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019-03-05, roč. 92, čís. 10. Dostupné online [cit. 2024-06-03]. ISSN0028-3878. DOI10.1212/WNL.0000000000007035. PMID30770430. (anglicky)
TIAN, Jingru; ZHANG, Dingyao; YAO, Xu. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Annals of the Rheumatic Diseases. 2023-03-01, roč. 82, čís. 3, s. 351–356. PMID: 36241363. Dostupné online [cit. 2024-06-03]. ISSN0003-4967. DOI10.1136/ard-2022-223035. PMID36241363. (anglicky)
NAVIAUX, R. K.; NAVIAUX, J. C.; LI, K. et al. Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences of the USA. 2016. Dostupné online. ISSN1091-6490.
LAM, Marco Ho-Bun; WING, Yun-Kwok; YU, Mandy Wai-Man. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine. 2009-12-14, roč. 169, čís. 22, s. 2142–2147. PMID: 20008700. Dostupné online [cit. 2024-06-02]. ISSN1538-3679. DOI10.1001/archinternmed.2009.384. PMID20008700.
FLUGE, Øystein; RISA, Kristin; LUNDE, Sigrid. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLOS ONE. 1. 7. 2015, roč. 10, čís. 7, s. e0129898. Dostupné online [cit. 2024-06-04]. ISSN1932-6203. DOI10.1371/journal.pone.0129898. PMID26132314. (anglicky)
FALK HVIDBERG, Michael; BRINTH, Louise Schouborg; OLESEN, Anne V. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PloS One. 2015, roč. 10, čís. 7, s. e0132421. PMID: 26147503
PMCID: PMC4492975. Dostupné online [cit. 2024-06-02]. ISSN1932-6203. DOI10.1371/journal.pone.0132421. PMID26147503.
pubmed.ncbi.nlm.nih.gov
LAM, Marco Ho-Bun; WING, Yun-Kwok; YU, Mandy Wai-Man. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine. 2009-12-14, roč. 169, čís. 22, s. 2142–2147. PMID: 20008700. Dostupné online [cit. 2024-06-02]. ISSN1538-3679. DOI10.1001/archinternmed.2009.384. PMID20008700.
FALK HVIDBERG, Michael; BRINTH, Louise Schouborg; OLESEN, Anne V. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PloS One. 2015, roč. 10, čís. 7, s. e0132421. PMID: 26147503
PMCID: PMC4492975. Dostupné online [cit. 2024-06-02]. ISSN1932-6203. DOI10.1371/journal.pone.0132421. PMID26147503.
plos.org
journals.plos.org
FLUGE, Øystein; RISA, Kristin; LUNDE, Sigrid. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLOS ONE. 1. 7. 2015, roč. 10, čís. 7, s. e0129898. Dostupné online [cit. 2024-06-04]. ISSN1932-6203. DOI10.1371/journal.pone.0129898. PMID26132314. (anglicky)
sagepub.com
journals.sagepub.com
VINK, Mark; VINK-NIESE, Alexandra. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review. Health Psychology Open. 2018-07, roč. 5, čís. 2, s. 205510291880518. Dostupné online [cit. 2024-06-04]. ISSN2055-1029. DOI10.1177/2055102918805187. (anglicky)
solen.cz
BYSTROŇ, Jaromír. Chornická únava a chronický únavový syndrom. Interní medicína pro praxi. 2006, čís. 3, s. 112–115. Dostupné online. ISSN1803-5256.
STEIDL, Ladislav. Chronický únavový syndrom. Interní medicína pro praxi. 2001, čís. 9, s. 394–396. Dostupné online. ISSN1803-5256.
What is Long Covid? [online]. [cit. 2024-06-02]. Dostupné online. (anglicky)
springer.com
link.springer.com
BECKER, Niels-Peter; HABERLAND, Annekathrin; WENZEL, Katrin. A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. Clinical Drug Investigation. 2020-05, roč. 40, čís. 5, s. 433–447. Dostupné online [cit. 2024-06-04]. ISSN1173-2563. DOI10.1007/s40261-020-00903-9. (anglicky)
szu.cz
L. Janečková: Chlamydiové infekce. SZÚ, Praha, Národní referenční laboratoř pro chlamydie. www.szu.cz [online]. [cit. 2010-09-01]. Dostupné v archivu pořízeném z originálu dne 2013-05-11.
tandfonline.com
DIAZ-MITOMA, Francisco; TURGONYI, Eva; KUMAR, Ashok. Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®. Journal of Chronic Fatigue Syndrome. 2003-01, roč. 11, čís. 2, s. 71–95. Dostupné online [cit. 2024-06-04]. ISSN1057-3321. DOI10.1300/J092v11n02_06. (anglicky)
unaids.org
Global HIV & AIDS statistics — Fact sheet. www.unaids.org [online]. [cit. 2024-06-03]. Dostupné online. (anglicky)
web.archive.org
L. Janečková: Chlamydiové infekce. SZÚ, Praha, Národní referenční laboratoř pro chlamydie. www.szu.cz [online]. [cit. 2010-09-01]. Dostupné v archivu pořízeném z originálu dne 2013-05-11.
wiley.com
onlinelibrary.wiley.com
HAKIM, Alan; DE WANDELE, Inge; O'CALLAGHAN, Chris. Chronic fatigue in Ehlers–Danlos syndrome—Hypermobile type. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017-03, roč. 175, čís. 1, s. 175–180. Dostupné online [cit. 2024-06-04]. ISSN1552-4868. DOI10.1002/ajmg.c.31542. (anglicky)
MALTSEV, Dmitry. A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis. Microbiology and Immunology. 2022-04, roč. 66, čís. 4, s. 193–199. Dostupné online [cit. 2024-06-04]. ISSN0385-5600. DOI10.1111/1348-0421.12966. (anglicky)
worldcat.org
DEVANUR, L. D.; KERR, J. R. Chronic fatigue syndrome. Journal of Clinical Virology. 2006, roč. 37, čís. 3, s. 139–150. Dostupné online. ISSN1386-6532. (anglicky)
VALDEZ, Ashley R.; HANCOCK, Elizabeth E.; ADEBAYO, Seyi. Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning. Frontiers in Pediatrics. 2019-01-08, roč. 6. Dostupné online [cit. 2024-06-03]. ISSN2296-2360. DOI10.3389/fped.2018.00412.
WALLIN, Mitchell T.; CULPEPPER, William J.; CAMPBELL, Jonathan D. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019-03-05, roč. 92, čís. 10. Dostupné online [cit. 2024-06-03]. ISSN0028-3878. DOI10.1212/WNL.0000000000007035. PMID30770430. (anglicky)
TIAN, Jingru; ZHANG, Dingyao; YAO, Xu. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Annals of the Rheumatic Diseases. 2023-03-01, roč. 82, čís. 3, s. 351–356. PMID: 36241363. Dostupné online [cit. 2024-06-03]. ISSN0003-4967. DOI10.1136/ard-2022-223035. PMID36241363. (anglicky)
BYSTROŇ, Jaromír. Chornická únava a chronický únavový syndrom. Interní medicína pro praxi. 2006, čís. 3, s. 112–115. Dostupné online. ISSN1803-5256.
NAVIAUX, R. K.; NAVIAUX, J. C.; LI, K. et al. Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences of the USA. 2016. Dostupné online. ISSN1091-6490.
STEIDL, Ladislav. Chronický únavový syndrom. Interní medicína pro praxi. 2001, čís. 9, s. 394–396. Dostupné online. ISSN1803-5256.
LAM, Marco Ho-Bun; WING, Yun-Kwok; YU, Mandy Wai-Man. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine. 2009-12-14, roč. 169, čís. 22, s. 2142–2147. PMID: 20008700. Dostupné online [cit. 2024-06-02]. ISSN1538-3679. DOI10.1001/archinternmed.2009.384. PMID20008700.
BAKER, Meghan; YOKOE, Deborah S.; STELLING, John. Automated Outbreak Detection of Hospital-Associated Infections. Open Forum Infectious Diseases. 2015, roč. 2, čís. suppl_1. Dostupné online [cit. 2024-06-04]. ISSN2328-8957. DOI10.1093/ofid/ofv131.60.
HAKIM, Alan; DE WANDELE, Inge; O'CALLAGHAN, Chris. Chronic fatigue in Ehlers–Danlos syndrome—Hypermobile type. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017-03, roč. 175, čís. 1, s. 175–180. Dostupné online [cit. 2024-06-04]. ISSN1552-4868. DOI10.1002/ajmg.c.31542. (anglicky)
WEIGEL, Breanna; EATON-FITCH, Natalie; THAPALIYA, Kiran. Symptom presentation and quality of life are comparable in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and post COVID-19 condition. Population Medicine. 2023-04-27, roč. 5, čís. Supplement. Dostupné online [cit. 2024-06-04]. ISSN2654-1459. DOI10.18332/popmed/165669.
Das Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen – IQWiG. Das Gesundheitswesen. 2018-12, roč. 80, čís. 12, s. 1107–1120. Dostupné online [cit. 2024-06-04]. ISSN0941-3790. DOI10.1055/a-0781-2253.
WEIGEL, Breanna; EATON-FITCH, Natalie; THAPALIYA, Kiran. Symptom presentation and quality of life are comparable in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and post COVID-19 condition. Population Medicine. 2023-04-27, roč. 5, čís. Supplement. Dostupné online [cit. 2024-06-04]. ISSN2654-1459. DOI10.18332/popmed/165669.
VINK, Mark; VINK-NIESE, Alexandra. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review. Health Psychology Open. 2018-07, roč. 5, čís. 2, s. 205510291880518. Dostupné online [cit. 2024-06-04]. ISSN2055-1029. DOI10.1177/2055102918805187. (anglicky)
HÄUSER, Winfried; BERNARDY, Kathrin; ÜÇEYLER, Nurcan. Treatment of Fibromyalgia Syndrome With Antidepressants: A Meta-analysis. JAMA. 2009-01-14, roč. 301, čís. 2, s. 198. Dostupné online [cit. 2024-06-04]. ISSN0098-7484. DOI10.1001/jama.2008.944. (anglicky)
BRUUN, Karin Due; AMRIS, Kirstine; VAEGTER, Henrik Bjarke. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021-12, roč. 22, čís. 1. Dostupné online [cit. 2024-06-04]. ISSN1745-6215. DOI10.1186/s13063-021-05776-7. (anglicky)
DIAZ-MITOMA, Francisco; TURGONYI, Eva; KUMAR, Ashok. Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®. Journal of Chronic Fatigue Syndrome. 2003-01, roč. 11, čís. 2, s. 71–95. Dostupné online [cit. 2024-06-04]. ISSN1057-3321. DOI10.1300/J092v11n02_06. (anglicky)
DE VINCI, Caterina; LEVINE, Paul H.; PIZZA, Giancarlo. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy. 1996-03-01, roč. 9, čís. 1, s. 87–90. Dostupné online [cit. 2024-06-04]. ISSN1573-8280. DOI10.1007/BF02628663. (anglicky)
MALTSEV, Dmitry. A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis. Microbiology and Immunology. 2022-04, roč. 66, čís. 4, s. 193–199. Dostupné online [cit. 2024-06-04]. ISSN0385-5600. DOI10.1111/1348-0421.12966. (anglicky)
LIANG, Shu-Ling; QUIRK, David; ZHOU, Aimin. RNase L: Its biological roles and regulation. IUBMB Life (International Union of Biochemistry and Molecular Biology: Life). 2006-09-01, roč. 58, čís. 9, s. 508–514. Dostupné online [cit. 2024-06-04]. ISSN1521-6543. DOI10.1080/15216540600838232.
FLUGE, Øystein; RISA, Kristin; LUNDE, Sigrid. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLOS ONE. 1. 7. 2015, roč. 10, čís. 7, s. e0129898. Dostupné online [cit. 2024-06-04]. ISSN1932-6203. DOI10.1371/journal.pone.0129898. PMID26132314. (anglicky)
BECKER, Niels-Peter; HABERLAND, Annekathrin; WENZEL, Katrin. A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. Clinical Drug Investigation. 2020-05, roč. 40, čís. 5, s. 433–447. Dostupné online [cit. 2024-06-04]. ISSN1173-2563. DOI10.1007/s40261-020-00903-9. (anglicky)
PRICE, J. R.; MITCHELL, E.; TIDY, E. et al. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev.. 2008, čís. 3, s. CD001027. ISSN1469-493X. (enhttp://creativecommons.org/licenses/by-sa/3.0/deed.cs)
FALK HVIDBERG, Michael; BRINTH, Louise Schouborg; OLESEN, Anne V. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). PloS One. 2015, roč. 10, čís. 7, s. e0132421. PMID: 26147503
PMCID: PMC4492975. Dostupné online [cit. 2024-06-02]. ISSN1932-6203. DOI10.1371/journal.pone.0132421. PMID26147503.
GHALI, Alaa; LACOUT, Carole; FORTRAT, Jacques-Olivier. Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2022-10, roč. 12, čís. 10, s. 2540. Dostupné online [cit. 2024-06-02]. ISSN2075-4418. DOI10.3390/diagnostics12102540. (anglicky)